Insulin-like growth factor-I and growth hormone administration in intestinal ischemia shock in the rat

Shock

Volumn 10, Issue 1, 1998, Pages 62-68

  Haglind, Eva ^a   Malmlof, Kjell ^b,d   Fan, Jie ^c   Lang, Charles H ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Peptide Hormones   (Sweden)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GROWTH HORMONE; INSULIN; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL; ARTICLE; BLOOD; FEMALE; GLUCOSE BLOOD LEVEL; INTESTINE; ISCHEMIA; MALE; METABOLISM; RAT; SHOCK; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; FEMALE; GROWTH HORMONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTESTINES; ISCHEMIA; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SHOCK;

EID: 0032113120     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199807000-00011     Document Type: Article

References (42)

1. Haglind E, Haglund U, Lundgren O, Romanus M, Schersten T: Graded intestinal vascular obstruction. I. Description of an experimental shock model in the rat. Circ Shock 7:83-91, 1980.
2. Haglind E, Haglund U, Lundgren O, Schersten T: Graded intestinal vascular obstruction. III. An analysis of pathogenic mechanisms. Circ Shock 8:335-341, 1981.
3. Haglind E, Haglund U, Lundgren O, Schersten T: Intestinal vascular obstruction in the rat: Effects of two dextran solutions on plasma volume, cardioinhibitory activity in blood and pulmonary trapping of platelets. Acta Chir Scand 153:87-92, 1987.
4. Haglind E, Haglund U, Lundgren O, Schersten T: Graded intestinal vascular obstruction. IV. Analysis of the patho-physiology in the development of refractory shock. Circ Shock 8:635-646, 1981.
5. Haglind E, Haglund U, Haljamae H: Liver metabolic effects of intestinal shock and naloxone treatment in the rat. Res Exp Med 188:197-207, 1988.
6. Haglind E: Effects of continuous naloxone infusion on intestinal ischemia shock in the rat. Circ Shock 38:195-201, 1992.
7. Aneman A, Medbak S, Watson D, Haglind E: Changes in circulating plasma met-enkephalin concentrations in feline intestinal ischaemia-reperfusion. Res Exp Med 194:129-138, 1994.
8. Nilsson U, Haglind E, Bylund-Fellenius AC, Lundgren: ESR measurement of radical production during in vivo intestinal ischemia and reperfusion in the cat. Am J Physiol 257:G409-G414, 1989.
9. Haglind E, Guanchi X, Rylander R: Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat. Circ Shock 43:83-91, 1994.
10. Haglind E, Wang D, Klein AS: Hepatic reticuloendothelial system dysfunction after intestinal ischemia-reperfusion. Shock 5:72-75, 1996.
11. Douglas RG, Shaw JHF: Metabolic response to sepsis and trauma. Br J Surg 76:115-122, 1989.
12. Fan J, Molina PE, Gelato MC, Lang CH: Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134:1685-1692, 1994.
13. Fan J, Li YH, Bagby GJ, Lang CH: Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock 4:21-26, 1995.
14. Lang CH, Fan J, Cooney R, Vary TC: Interleukin-1 receptor antagonist attenuates sepsis-induced alterations in the insulin-like growth factor system and protein synthesis. Am J Physiol 270:E430-E437, 1996.
15. Lang CH, Fan J, Frost RA, et al: Regulation of the insulin-like growth factor system by insulin in burn patients. J Clin Endocrinol Metabol 81:2474-2480, 1996.
16. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH: Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 268: R970-R977, 1995.
17. Rodriguez-Arnao J, Yarwood G, Ferguson C, Miell J, Hinds CJ, Ross RJM: Reduction in circulating IGF-I and hepatic IGF-I mRNA levels after caecal ligation and puncture are associated with differential regulation of hepatic IGF-binding protein-1, -2 and -3 mRNA levels. J Endocrinol 151:287-292, 1996.
18. Dardevet D, Sornet C, Attaix D, Baracos VE, Grizard JE: Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Endocrinology 134:1475-1484, 1994.
19. Meyer MA, Barrow RE, Herndon DN: Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats. J Trauma 41:1008-1012, 1996.
20. Peterson SR, Holaday NJ, Jeevanandam M: Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone. J Trauma 36:726-733, 1994.
21. Tomas FM, Chandler CS, Coyle P, Bourgeois CS, Burgoyne JL, Rofe AM: Effects of insulin and insulin-like growth factors on protein and energy metabolism in tumour-bearing rats. Biochem J 301:769-775, 1994.
22. Meyer NA, Barrow RE, Herndon DN: Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats. J Trauma 41:1008-1012, 1996.
23. Chomczynski P, Sacchi, N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extract. Anal Biochem 162: 156-159, 1986.
24. Fan J, Wojnar MM, Theodorakis M, Lang CH: Regulation of insulin-like growth factor (IGF)-I mRNA and peptide, and IGF-binding proteins by interleukin-1. Am J Physiol 270:R621-R629, 1996.
25. LI YH, Fan J, Lang CH: Role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGF binding protein-1. Am J Physiol 272:R1970-R1977, 1997.
26. Adamo ML, Ben-Hur H, Roberts CT, LeRoith D: Regulation of start-site usage in the leader exons of the rate insulin-like growth factor-I gene by development, fasting and diabetes. Mol Endocrinol 5:1677-1686, 1991.
27. Fan J, Char D, Bagby GJ, Gelato MC, Lang CH: Regulation of insulin-like growth factor (IGF)-I and IGF-binding proteins by tumor necrosis factor. Am J Physiol 269:R1204-R1212, 1995.
28. Wolf M, Bohm S, Brand M, Kreymann G: Proinflammatory cytokines interleukin-1β and tumor necrosis factor a inhibit growth hormone stimulation of insulin-like growth factor-I synthesis and growth hormone receptor mRNA levels in cultured rats liver cells. Eur J Endocrinol 135:729-737, 1996.
29. Grotz MR, Ding J, Guo W, Huang Q, Deitch EA: Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3:362-368, 1995.
30. Wyble CW, Desai TR, Clark ET, Hynes KL, Gewertz BL: Physiological concentration of TNFβ and IL-1β released from reperfused human intestine upregulate E-selectin and ICAM-1. J Surg Res 63:333-338, 1996.
31. McNurlan MA, Garlick PJ, Steigbigel RT, et al: Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease. J Clin Invest 100:2125-2132, 1997.
32. Clemmons DR, Smith-Banks A, Underwood LE: Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. J Clin Endocrinol Metabol 75:234-238, 1992.
33. Fan J, Char D, Kolasa AJ, et al: Alterations in hepatic production and peripheral clearance of IGF-I after endotoxin. Am J Physiol 269:E33-E42, 1995.
34. Dahn MS, Lange MP, Jacobs LA: Insulinlike growth factor 1 production is inhibition in human sepsis. Arch Surg 123:1409-1414, 1988.
35. Belcher HJCR, Ellis H: An investigation of the anabolic activity of somatropin in normal and burned rats. Burns 16:17-20, 1990.
36. Mathews LS, Norstedt G, Palmiter RD: Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 83:9343-9347, 1986.
37. Jones JL, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34, 1995.
38. Lee PDK, Conover CA, Powell DR: Regulation and function of insulin-like growth factor-binding protein-1. Proc Soc Exp Biol Med 204:4-29, 1993.
39. Elahi D, McAloon-Dyke M, Fukagawa MK, et al: Effects of recombinant IGF-I on glucose and leucine kinetics in men. Am J Physiol 265:E831-E838, 1993.
40. Russell-Jones DL, Umpleby AM, Hennessy TR, et al: Use of a leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans. Am J Physiol 267:E591-E598, 1994.
41. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR: Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396, 1993.
42. Leahy JL, Venderkerkhove KM: Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126:1593-1598, 1990.